For instance, impairments in lipid and glucose profiles can lead to poor MS disease prognosis [26], specifically with increased total cholesterol (TC), low-density lipoprotein (LDL), triglyceride (TG), and insulin levels being associated with increased MS disability progression [27]. The gene discussed is INS; the disease is myeloid sarcoma.